Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Sberbank reported for 2023 by RAS

1/17/24 SBER

VMTP again first in Russia in terms of container turnover

1/17/24 FESH

SFI shareholder redomiciled to Russia

1/16/24 SFIN

Sovcomflot will transport almost 1.7 million tons of hydrocarbons through the NSR in 2023

1/16/24 FLOT

Price of redemption of LSR shares from Arsagera funds became known

1/16/24 ARSA

Price of redemption of LSR shares from Arsagera funds became known

1/16/24 LSRG

TCS Group may complete the redomiciliation as early as the first quarter of 2024

1/16/24 T

European Electrotechnics started a buyback

1/16/24 EELT

Fesco acquires 11 new container cranes for VMTP

1/16/24 FESH

PhosAgro's production complex in Balakovo ended 2023 with record results

1/16/24 PHOR